Walmart shares technical analysis: Upward price move as buyer support strengthens intraday

Traders Union
All News
Stocks
Walmart jumps 3.03% to $115.68 today

Highlights

Walmart expanded healthcare benefits for staff in 2024, adding over 250 free prescription drugs including GLP-1s and insulin.
The FDA sent Walmart a warning about marketing unapproved STI drug products on its website, indicating regulatory scrutiny of its health offerings.
Walmart stock traded with strong short- and medium-term momentum, finishing up 3.03% and projected to consolidate in a $110.94 to $118.38 range.

Benefit expansions, FDA scrutiny, and automation shape sentiment

Walmart has expanded its employee healthcare benefits for 2024, offering more than 250 prescription medications—including GLP-1s, insulin, and inhalers—at no cost to eligible employees, a move reported by CNBC that may reduce employee turnover and aid cost management. Separately, the U.S. FDA issued Walmart a warning letter for marketing unapproved and misbranded sexually transmitted infection drug products on its website, signaling regulatory oversight of its health marketplace, according to Simplywall. Walmart also opened its fifth next-generation fulfillment center in Stockton, California, an automation-driven facility expected to employ about 1,000 people, according to Yahoo Finance, while recent insider selling by Executive Vice President Daniel Bartlett was disclosed by Investing.com.

Bullish momentum builds as overbought signals test resistance

On the charts, WMT/USD is trading above its MA-20 and MA-50 on the hourly timeframe, but stays below the MA-200 on the daily chart. The Ichimoku Kijun at $112.67 offers immediate support. Momentum indicators are strongly positive, with MACD rated Strong Buy and ADX pointing to bullish conditions. RSI is high at 74.65, with both Stoch RSI and CCI indicating overbought levels, while Bull/Bear Power shows buyers dominating intraday trading. The Awesome Oscillator is neutral and does not confirm the short-term trend.

Consolidation outlook holds with breakouts poised to shift momentum

Over the coming sessions, the expected price range is $110.94 to $118.38. The probability of an upward move is very high, and a decline appears unlikely. The baseline scenario calls for price consolidation within this band, though a break above $118.38 could trigger renewed buying and upward momentum. Conversely, a move below $110.94 would expose the market to further downside pressure.

Anton Kharitonov, Traders Union expert, sees short-term momentum remaining positive for Walmart as technical indicators stay bullish. He notes that while recent employee benefit expansions and supply chain investments support sentiment, regulatory scrutiny and insider selling are clear risk factors. Price consolidation above $110.94 is his base case, with upside only confirmed on a break of $118.38. "I remain cautious — unless Walmart clears resistance at $118.38, the risk of reversal persists."

Earlier, analysts noted that rising freight and input costs were driving renewed pricing pressures across the U.S. grocery sector, with companies like Walmart working to offset inflation while maintaining affordability. In light of Walmart's latest operational investments and healthcare benefit expansions, the prevailing scenario suggests traders should keep an eye on price action around the $118.38 level, as any breakout could trigger new momentum beyond the current consolidation range.

Source of Data: WMT Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.